Is oral rapamycin plus bare metal stents a feasible alternative to drug eluting stents to prevent restenosis? A cost effective follow up analysis from the randomized, controlled ORAR III study

被引:0
|
作者
Rodriguez, A. E. [1 ]
Mieres, J. [1 ]
Rodriguez-Granillo, A. M. [1 ]
Fernandez-Pereira, C. [1 ]
Felssen, M. R. [1 ]
Curotto, V. [1 ]
Tarragona, S. [1 ]
Mauree, A. [2 ]
Palacios, I. [1 ]
机构
[1] Otamendi Hosp, Cardiovasc Res Ctr, Buenos Aires, DF, Argentina
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:396 / 396
页数:1
相关论文
共 50 条
  • [1] Bare metal stents plus oral rapamycin are more cost effective than drug eluting stents in patients undergoing PCI for de novo coronary lesions: Insights from the randomized,controlled ORAR III study
    Fernandez-Pereira, Carlos
    Mieres, Juan
    Risau, Gustavo
    Santaera, Omar
    Rodriguez-Granillo, Alfredo M.
    Rodriguez-Granillo, Gaston A.
    Mauree, Andrew O.
    Palacios, Igor F.
    Rodriquez, Alfredo E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B88 - B88
  • [2] Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: Three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial
    Rodriguez, Alfredo E.
    Rodriguez-Granillo, Alfredo M.
    Antoniucci, David
    Mieres, Juan
    Fernandez-Pereira, Carlos
    Rodriguez-Granillo, Gaston A.
    Santaera, Omar
    Rubilar, Bibiana
    Palacios, Igor F.
    Serruys, Patrick W.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 80 (03) : 385 - 394
  • [3] Comparison of Cost-Effectiveness of Oral Rapamycin Plus Bare-Metal Stents Versus First Generation of Drug-Eluting Stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 Trial)
    Rodriguez, Alfredo E.
    Palacios, Igor
    Rodriguez-Granillo, Alfredo M.
    Mieres, Juan R.
    Tarragona, Sonia
    Fernandez-Pereira, Carlos
    Solorzano, Leonardo
    Pauletto, Ricardo
    Serruys, Patrick W.
    Antoniucci, David
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (05) : 815 - 821
  • [4] Percutaneous Coronary Intervention with Bare Metal Stents and Oral Sirolimus has Comparable Safety and Efficacy to Treatment with Drug Eluting Stents but with Significant Cost Saving : Long Term Follow Up Results From the Randomized, Controlled ORAR III (Oral Rapamycin in Argentina) Study
    Rodriguez, Alfredo
    Maree, Andrew
    Tarragona, Sonia
    Fernandez-Pereira, Carlos
    Rodriguez-Granillo, Alfredo M.
    Rodriguez-Granillo, Gaston A.
    Santaera, Omar
    Mieres, Juan
    Kukreja, Neville
    Antoniucci, David
    Palacios, Igor F.
    Serruys, Patrick W.
    CIRCULATION, 2008, 118 (18) : S1051 - S1051
  • [5] Percutaneous Coronary Intervention With Bare Metal Stents and Oral Sirolimus Has Comparable Safety and Efficacy to Treatment With Drug Eluting Stents but With Significant Lower Cost: 31 Months Cost Saving and Clinical Events Analysis From the Randomized, Controlled ORAR III (Oral Rapamycin in Argentina) Study
    Fernandez-Pereira, Carlos
    Rubilar, Bibiana
    Mieres, Juan
    Rodriguez-Pagani, Carlos
    Santaera, Omar
    Rodriguez-Granillo, Alfredo M.
    Antoniucci, David
    Palacios, Igor F.
    Serruys, Patrick W.
    Rodriguez, Alfredo E.
    CIRCULATION, 2009, 120 (18) : S967 - S967
  • [6] Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR Ill (Oral Rapamycin in ARgentina) study
    Rodriguez, Alfredo E.
    Maree, Andrew
    Tarragona, Sonia
    Fernandez-Pereira, Carlos
    Santaera, Omar
    Rodriguez Granillo, Alfredo M.
    Rodriguez-Granillo, Gaston A.
    Russo-Felssen, Miguel
    Kukreja, Neville
    Antoniucci, David
    Palacios, Igor F.
    Serruys, Patrick W.
    EUROINTERVENTION, 2009, 5 (02) : 255 - 264
  • [7] PERCUTANEOUS CORONARY INTERVENTIONS WITH ORAL SIROLIMUS AND BARE METAL STENTS ARE COMPARABLE IN SAFETY AND EFFICACY RESULTS TO DRUG ELUTING STENTS: THREE YEARS OUTCOME FROM THE RANDOMIZED ORAR III TRIAL
    Rodriguez, Alfredo E.
    Rodriguez-Granillo, Alfredo M.
    Mieres, Juan
    Fernandez-Pereira, Carlos
    Santaera, Omar
    Rodriguez-Granillo, Gaston A.
    Rubilar, Bibiana
    Antoniucci, David
    Palacios, Igor F.
    Serruys, Patrick W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1637 - E1637
  • [8] Randomized Comparison of Bare Metal Stents Plus Colchicine vs Drug Eluting Stents: Preliminary Analysis of the Orca Trial (Oral Colchicine in Argentina)
    Rodriguez-Granillo, Alfredo Matias M.
    Sadouet, Camila Correa
    Mieres, Juan
    Fernandez-Pereira, Carlos
    Cristodulo, Roberto
    Pavlovsky, Hernan
    Curotto, Valeria
    Swieszkowski, Sandra
    Milei, Jose
    Barbagelata, Alejandro
    Kastrati, Adnan
    Rodriguez, Alfredo E.
    CIRCULATION, 2022, 146
  • [9] Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis - The prospective, randomized oral rapamycin in Argentina (ORAR II) study
    Rodriguez, AE
    Granada, JF
    Rodriguez-Alemparte, M
    Vigo, CF
    Delgado, J
    Fernandez-Pereira, C
    Pocovi, A
    Rodriguez-Granillo, AM
    Schulz, D
    Raizner, AE
    Palacios, I
    O'Neill, W
    Kaluza, GL
    Stone, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) : 1522 - 1529
  • [10] Late Catch-up Restenosis of Drug Eluting Stents: Evidence from Comparison with Bare Metal Stents in Japanese CAD Patients
    Horita, Yuki
    Ikeda, Masatoshi
    Inoki, Isao
    Namura, Masanobu
    Sakata, Kenji
    Terai, Hedenobu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B185 - B186